AUA 2017 Kidney Cancer - Results from #20

Viewing 21-36 of 36 articles

AUA 2017: The nuclear grade and prognosis are unrelated to the TNM stage in multilocular cystic renal cell neoplasm of low malignant potential

AUA 2017: The Comprehensive Complication Index (CCI) is superior to the Clavien-Dindo grading system in predicting length of stay and hospital readmission following radical nephroureterectomy

AUA 2017: Utility of preoperative MRI in characterizing the parenchymal-tumor interface of renal masses prior to surgical intervention

AUA 2017: Predicting Renal Cell Carcinoma Progression after Surgery

AUA 2017: The Superior Preservation of Postoperative Renal Function in Robotic Partial Nephrectomy, Compared with Laparoscopy, is Associated with Reduced Parenchymal Volume Loss and Not Shorter Renal Ischemia Time: A Propensity Scored-Matched Analysis

AUA 2017: Phase 3 Randomized Trial of Intravenous Mannitol Versus Placebo Prior To Renal Ischemia During Partial Nephrectomy: Impact on Renal Function Outcomes

Phase 3 Randomised Trial of Intravenous Mannitol Versus Placebo During Nephron-Sparing Surgery: Impact on Renal Function Outcomes

AUA 2017: Excised Parenchymal Mass and Devascularized Parenchymal Mass

AUA 2017: Additive Prognostic Impact of Elevated De Ritis Ratio and Renal Score for Prediction of Survival Outcomes in Renal Cell Carcinoma After Surgical Treatment

AUA 2017: American Urological Association Guidelines 2017 Renal Cancer: Localized

AUA 2017: Prediction of Histological Subtypes of Small Renal Masses: Striving for a Standardized MRI Diagnostic Algorithm

AUA 2017: Active Surveillance for Cystic Renal Masses with 5 or More Years of Follow-Up

AUA 2017: Robot-Assisted Radical Nephrectomy and Inferior Vena Cava Thrombectomy: Surgical Technique and Perioperative and Oncologic Outcomes

AUA 2017: The Effect of Anatomic Location of Retroperitoneal Lymph Node Metastases on Cancer-Specific Survival in Patients with Clear Cell Carcinoma

AUA 2017: Survival Following Neoadjuvant Targeted Therapy and Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma Patients

AUA 2017: Adjuvant Sunitinib in Patients with High-Risk Renal Cell Carcinoma: Subgroup Analysis from S-TRAC Trial

1
2